ANI Pharmaceuticals | ANIP - Devedores Comerciais

Preço das Ações
73.52
Mudança Diária
-0.40 -0.54%
Mensal
-3.64%
Anual
10.84%
Q1 Previsão
72.43




Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Assertio Holdings USD 39.91M 2.7M 2024-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Canopy Growth CAD 140.42M 113.56M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
Perrigo USD 612.8M 31.6M 2025-12
Sun Pharmaceuticals INR 157.04B 26.1B 2025-09
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12